1-111699173-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002884.4(RAP1A):c.183+1676A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.132 in 151,076 control chromosomes in the GnomAD database, including 1,535 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.13   (  1535   hom.,  cov: 30) 
Consequence
 RAP1A
NM_002884.4 intron
NM_002884.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  1.47  
Publications
6 publications found 
Genes affected
 RAP1A  (HGNC:9855):  (RAP1A, member of RAS oncogene family) This gene encodes a member of the Ras family of small GTPases. The encoded protein undergoes a change in conformational state and activity, depending on whether it is bound to GTP or GDP. This protein is activated by several types of guanine nucleotide exchange factors (GEFs), and inactivated by two groups of GTPase-activating proteins (GAPs). The activation status of the encoded protein is therefore affected by the balance of intracellular levels of GEFs and GAPs. The encoded protein regulates signaling pathways that affect cell proliferation and adhesion, and may play a role in tumor malignancy. Pseudogenes of this gene have been defined on chromosomes 14 and 17. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.2  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.133  AC: 20005AN: 150958Hom.:  1537  Cov.: 30 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
20005
AN: 
150958
Hom.: 
Cov.: 
30
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.132  AC: 20008AN: 151076Hom.:  1535  Cov.: 30 AF XY:  0.135  AC XY: 9963AN XY: 73806 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
20008
AN: 
151076
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
9963
AN XY: 
73806
show subpopulations 
African (AFR) 
 AF: 
AC: 
3326
AN: 
41140
American (AMR) 
 AF: 
AC: 
2883
AN: 
15188
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
582
AN: 
3464
East Asian (EAS) 
 AF: 
AC: 
1082
AN: 
5136
South Asian (SAS) 
 AF: 
AC: 
543
AN: 
4786
European-Finnish (FIN) 
 AF: 
AC: 
1876
AN: 
10304
Middle Eastern (MID) 
 AF: 
AC: 
45
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
9356
AN: 
67752
Other (OTH) 
 AF: 
AC: 
294
AN: 
2100
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.506 
Heterozygous variant carriers
 0 
 870 
 1740 
 2611 
 3481 
 4351 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 236 
 472 
 708 
 944 
 1180 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
579
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.